Evaluation of patients with hereditary hemorrhagic telangiectasia with video capsule endoscopy: A single-center prospective study

S. M. Chamberlain, J. Patel, J. Carter Balart, James R Gossage, Subbaramiah Sridhar

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background and study aims: Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder characterized by telangiectasia formation that can lead to small-bowel bleeding. In this study, video capsule endoscopy was used to compare the small-bowel findings observed in patients with HHT with those seen in patients without the condtion. Patients and methods: We performed capsule endoscopy studies in 93 consecutive patients who were being evaluated for small-bowel bleeding, 38 patients with known or suspected HHT and 55 patients without HHT. Nine patients were excluded because the capsule failed to reach the cecum. The findings in 32 patients with a final diagnosis of HHT and in 48 patients without HHT were recorded and compared. Results: Capsule endoscopy detected telangiectases evenly distributed throughout the small bowel in 26/32 (81%) patients with HHT, compared with 14/48 (29%) in patients without HHT. When active bleeding was observed in patients with HHT (n=4), the bleeding was within reach of standard small-bowel push enteroscopy in all cases. The presence of five or more gastrointestinal telangiectases by capsule endoscopy had a sensitivity of 75% and a positive predictive value of 86% for diagnosing HHT. Unexpected findings (small-bowel polyps and mass-like lesiops) were seen in both groups of patients (6.2% in patients with HHT and 2.1% in patients without HHT). Conclusions: Small-bowel telangiectases were seen in the majority of patients with HHT and were evenly distributed throughout the small bowel. Telangiectases were observed in only a minority of patients who did not have HHT. Actively bleeding small-bowel telangiectases were located in the proximal and mid-small bowel in patients with HHT, all within reach of an enteroscope. We propose a cutoff point of at east five gastrointestinal telangiectases to suppott a diagnosis of HHT.

Original languageEnglish (US)
Pages (from-to)516-520
Number of pages5
JournalEndoscopy
Volume39
Issue number6
DOIs
StatePublished - Jun 1 2007

Fingerprint

Capsule Endoscopy
Hereditary Hemorrhagic Telangiectasia
Prospective Studies
Telangiectasis
Hemorrhage

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Evaluation of patients with hereditary hemorrhagic telangiectasia with video capsule endoscopy : A single-center prospective study. / Chamberlain, S. M.; Patel, J.; Carter Balart, J.; Gossage, James R; Sridhar, Subbaramiah.

In: Endoscopy, Vol. 39, No. 6, 01.06.2007, p. 516-520.

Research output: Contribution to journalArticle

@article{b4c8c6c3321747a581f2b0b66b175087,
title = "Evaluation of patients with hereditary hemorrhagic telangiectasia with video capsule endoscopy: A single-center prospective study",
abstract = "Background and study aims: Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder characterized by telangiectasia formation that can lead to small-bowel bleeding. In this study, video capsule endoscopy was used to compare the small-bowel findings observed in patients with HHT with those seen in patients without the condtion. Patients and methods: We performed capsule endoscopy studies in 93 consecutive patients who were being evaluated for small-bowel bleeding, 38 patients with known or suspected HHT and 55 patients without HHT. Nine patients were excluded because the capsule failed to reach the cecum. The findings in 32 patients with a final diagnosis of HHT and in 48 patients without HHT were recorded and compared. Results: Capsule endoscopy detected telangiectases evenly distributed throughout the small bowel in 26/32 (81{\%}) patients with HHT, compared with 14/48 (29{\%}) in patients without HHT. When active bleeding was observed in patients with HHT (n=4), the bleeding was within reach of standard small-bowel push enteroscopy in all cases. The presence of five or more gastrointestinal telangiectases by capsule endoscopy had a sensitivity of 75{\%} and a positive predictive value of 86{\%} for diagnosing HHT. Unexpected findings (small-bowel polyps and mass-like lesiops) were seen in both groups of patients (6.2{\%} in patients with HHT and 2.1{\%} in patients without HHT). Conclusions: Small-bowel telangiectases were seen in the majority of patients with HHT and were evenly distributed throughout the small bowel. Telangiectases were observed in only a minority of patients who did not have HHT. Actively bleeding small-bowel telangiectases were located in the proximal and mid-small bowel in patients with HHT, all within reach of an enteroscope. We propose a cutoff point of at east five gastrointestinal telangiectases to suppott a diagnosis of HHT.",
author = "Chamberlain, {S. M.} and J. Patel and {Carter Balart}, J. and Gossage, {James R} and Subbaramiah Sridhar",
year = "2007",
month = "6",
day = "1",
doi = "10.1055/s-2007-966349",
language = "English (US)",
volume = "39",
pages = "516--520",
journal = "Endoscopy",
issn = "0013-726X",
publisher = "Georg Thieme Verlag",
number = "6",

}

TY - JOUR

T1 - Evaluation of patients with hereditary hemorrhagic telangiectasia with video capsule endoscopy

T2 - A single-center prospective study

AU - Chamberlain, S. M.

AU - Patel, J.

AU - Carter Balart, J.

AU - Gossage, James R

AU - Sridhar, Subbaramiah

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Background and study aims: Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder characterized by telangiectasia formation that can lead to small-bowel bleeding. In this study, video capsule endoscopy was used to compare the small-bowel findings observed in patients with HHT with those seen in patients without the condtion. Patients and methods: We performed capsule endoscopy studies in 93 consecutive patients who were being evaluated for small-bowel bleeding, 38 patients with known or suspected HHT and 55 patients without HHT. Nine patients were excluded because the capsule failed to reach the cecum. The findings in 32 patients with a final diagnosis of HHT and in 48 patients without HHT were recorded and compared. Results: Capsule endoscopy detected telangiectases evenly distributed throughout the small bowel in 26/32 (81%) patients with HHT, compared with 14/48 (29%) in patients without HHT. When active bleeding was observed in patients with HHT (n=4), the bleeding was within reach of standard small-bowel push enteroscopy in all cases. The presence of five or more gastrointestinal telangiectases by capsule endoscopy had a sensitivity of 75% and a positive predictive value of 86% for diagnosing HHT. Unexpected findings (small-bowel polyps and mass-like lesiops) were seen in both groups of patients (6.2% in patients with HHT and 2.1% in patients without HHT). Conclusions: Small-bowel telangiectases were seen in the majority of patients with HHT and were evenly distributed throughout the small bowel. Telangiectases were observed in only a minority of patients who did not have HHT. Actively bleeding small-bowel telangiectases were located in the proximal and mid-small bowel in patients with HHT, all within reach of an enteroscope. We propose a cutoff point of at east five gastrointestinal telangiectases to suppott a diagnosis of HHT.

AB - Background and study aims: Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder characterized by telangiectasia formation that can lead to small-bowel bleeding. In this study, video capsule endoscopy was used to compare the small-bowel findings observed in patients with HHT with those seen in patients without the condtion. Patients and methods: We performed capsule endoscopy studies in 93 consecutive patients who were being evaluated for small-bowel bleeding, 38 patients with known or suspected HHT and 55 patients without HHT. Nine patients were excluded because the capsule failed to reach the cecum. The findings in 32 patients with a final diagnosis of HHT and in 48 patients without HHT were recorded and compared. Results: Capsule endoscopy detected telangiectases evenly distributed throughout the small bowel in 26/32 (81%) patients with HHT, compared with 14/48 (29%) in patients without HHT. When active bleeding was observed in patients with HHT (n=4), the bleeding was within reach of standard small-bowel push enteroscopy in all cases. The presence of five or more gastrointestinal telangiectases by capsule endoscopy had a sensitivity of 75% and a positive predictive value of 86% for diagnosing HHT. Unexpected findings (small-bowel polyps and mass-like lesiops) were seen in both groups of patients (6.2% in patients with HHT and 2.1% in patients without HHT). Conclusions: Small-bowel telangiectases were seen in the majority of patients with HHT and were evenly distributed throughout the small bowel. Telangiectases were observed in only a minority of patients who did not have HHT. Actively bleeding small-bowel telangiectases were located in the proximal and mid-small bowel in patients with HHT, all within reach of an enteroscope. We propose a cutoff point of at east five gastrointestinal telangiectases to suppott a diagnosis of HHT.

UR - http://www.scopus.com/inward/record.url?scp=34250685734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250685734&partnerID=8YFLogxK

U2 - 10.1055/s-2007-966349

DO - 10.1055/s-2007-966349

M3 - Article

C2 - 17554646

AN - SCOPUS:34250685734

VL - 39

SP - 516

EP - 520

JO - Endoscopy

JF - Endoscopy

SN - 0013-726X

IS - 6

ER -